Biomarker analysis of the multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)
Refereed conference paper presented and published in conference proceedings


全文

其它資訊
著者Edwin Pun Hui, Anthony T. C. Chan, Roger K.C. Ngan, Stewart Yuk Tung, Ashley Chi Kin Cheng, Wai Tong Ng, Victor HF Lee, Brigette Ma, Hoi Ching Cheng, Frank C.S. Wong, Herbert H. F. Loong, Macy Tong, Daren MC Poon, Anil Tejbhan Ahuja, Ann Dorothy King, Ki Wang, Frankie Mo, Benny C.Y. Zee, Allen K.C. Chan, YM Dennis Lo
會議名稱European Society For Medical Oncology (ESMO) Congress 2017
會議開始日08.09.2017
會議完結日12.09.2017
會議地點Madrid
會議國家/地區西班牙
出版年份2017
月份9
語言英式英語

上次更新時間 2018-28-11 於 10:34